MedTrace Logo

Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age with Type 1 Diabetes

NCT06253351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2024-11-26

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of hybrid closed loop on glycemic outcomes in young patients aged between 15 and 25 years old with type 1 diabetes, whatever is their initial metabolic control.

Conditions

  • Type1 Diabetes
  • Adolescents
  • Young Adults

Interventions

DEVICE

Hybrid closed loop (HCL)

* Control IQ : T-Slim pump with Dexcom G6 * Smartguard : Medtronic 780G pump with Guardian G4S * Diabeloop : Kaliedo pump with Dexcom G6

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Juliette EROUKHMANOFF, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2024-05-06
Completion
2024-05-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06253351 on ClinicalTrials.gov